485 related articles for article (PubMed ID: 30089749)
1. The clinical impact of human T-lymphotrophic virus type 1 (HTLV-1) infection on the development of adult T-cell leukemia-lymphoma (ATL) or HTLV-1-associated myelopathy (HAM) / atypical HAM after allogeneic hematopoietic stem cell transplantation (allo-HSCT) and renal transplantation.
Kawano N; Yoshida S; Kawano S; Kuriyama T; Tahara Y; Toyofuku A; Manabe T; Doi A; Terasaka S; Yamashita K; Ueda Y; Ochiai H; Marutsuka K; Yamano Y; Shimoda K; Kikuchi I
J Clin Exp Hematop; 2018 Sep; 58(3):107-121. PubMed ID: 30089749
[TBL] [Abstract][Full Text] [Related]
2. Allogeneic hematopoietic stem cell transplantation for adult T-cell leukemia/lymphoma with HTLV-1-associated myelopathy.
Sakamoto H; Itonaga H; Sawayama Y; Kojima A; Chiwata M; Fujioka M; Kitanosono H; Horai M; Miyazaki T; Shiraishi H; Imaizumi Y; Yoshida S; Hata T; Yamano Y; Miyazaki Y
Int J Hematol; 2021 May; 113(5):765-769. PubMed ID: 33423163
[TBL] [Abstract][Full Text] [Related]
3. A retrospective analysis of treatment outcomes in adult T cell leukemia/lymphoma patients with aggressive disease treated with or without allogeneic stem cell transplantation: A single-center experience.
Kawada H; Yoshimitsu M; Nakamura D; Arai A; Hayashida M; Kamada Y; Maekawa K; Fujino S; Arima M; Arima N; Tabuchi T; Inoue H; Hamda H; Suzuki S; Matsushita K; Arima N
Biol Blood Marrow Transplant; 2015 Apr; 21(4):696-700. PubMed ID: 25542158
[TBL] [Abstract][Full Text] [Related]
4. Single-cell analysis of T-cell receptor repertoire of HTLV-1 Tax-specific cytotoxic T cells in allogeneic transplant recipients with adult T-cell leukemia/lymphoma.
Tanaka Y; Nakasone H; Yamazaki R; Sato K; Sato M; Terasako K; Kimura S; Okuda S; Kako S; Oshima K; Tanihara A; Nishida J; Yoshikawa T; Nakatsura T; Sugiyama H; Kanda Y
Cancer Res; 2010 Aug; 70(15):6181-92. PubMed ID: 20647322
[TBL] [Abstract][Full Text] [Related]
5. Potential contribution of a novel Tax epitope-specific CD4+ T cells to graft-versus-Tax effect in adult T cell leukemia patients after allogeneic hematopoietic stem cell transplantation.
Tamai Y; Hasegawa A; Takamori A; Sasada A; Tanosaki R; Choi I; Utsunomiya A; Maeda Y; Yamano Y; Eto T; Koh KR; Nakamae H; Suehiro Y; Kato K; Takemoto S; Okamura J; Uike N; Kannagi M
J Immunol; 2013 Apr; 190(8):4382-92. PubMed ID: 23475215
[TBL] [Abstract][Full Text] [Related]
6. A retrospective analysis of allogeneic hematopoietic stem cell transplantation for adult T cell leukemia/lymphoma (ATL): clinical impact of graft-versus-leukemia/lymphoma effect.
Shiratori S; Yasumoto A; Tanaka J; Shigematsu A; Yamamoto S; Nishio M; Hashino S; Morita R; Takahata M; Onozawa M; Kahata K; Kondo T; Ota S; Wakasa K; Sugita J; Koike T; Asaka M; Kasai M; Imamura M
Biol Blood Marrow Transplant; 2008 Jul; 14(7):817-23. PubMed ID: 18541202
[TBL] [Abstract][Full Text] [Related]
7. The Impact of a Humanized CCR4 Antibody (Mogamulizumab) on Patients with Aggressive-Type Adult T-Cell Leukemia-Lymphoma Treated with Allogeneic Hematopoietic Stem Cell Transplantation.
Kawano N; Kuriyama T; Yoshida S; Kawano S; Yamano Y; Marutsuka K; Minato S; Yamashita K; Ochiai H; Shimoda K; Ishikawa F; Kikuchi I
J Clin Exp Hematop; 2017; 56(3):135-144. PubMed ID: 28331127
[TBL] [Abstract][Full Text] [Related]
8. [Allogeneic hematopoietic stem cell transplantation for adult T-cell leukemia-lymphoma].
Utsunomiya A
Rinsho Ketsueki; 2016; 57(10):2190-2198. PubMed ID: 27795530
[TBL] [Abstract][Full Text] [Related]
9. Small number of HTLV-1-positive cells frequently remains during complete remission after allogeneic hematopoietic stem cell transplantation that are heterogeneous in origin among cases with adult T-cell leukemia/lymphoma.
Yamasaki R; Miyazaki Y; Moriuchi Y; Tsutsumi C; Fukushima T; Yoshida S; Taguchi J; Inoue Y; Matsuo E; Imaizumi Y; Imanishi D; Fujimoto T; Tsushima H; Honda S; Hata T; Tsukasaki K; Tomonaga M
Leukemia; 2007 Jun; 21(6):1212-7. PubMed ID: 17410191
[TBL] [Abstract][Full Text] [Related]
10. [Adult T cell leukemia-lymphoma with allo-HSCT after treatment for pulmonary involvement with Mogamulizumab].
Kawashima I; Sueki Y; Yamamoto T; Nozaki Y; Nakajima K; Mitsumori T; Kirito K
Rinsho Ketsueki; 2015 Feb; 56(2):210-5. PubMed ID: 25765802
[TBL] [Abstract][Full Text] [Related]
11. Graft-versus-Tax response in adult T-cell leukemia patients after hematopoietic stem cell transplantation.
Harashima N; Kurihara K; Utsunomiya A; Tanosaki R; Hanabuchi S; Masuda M; Ohashi T; Fukui F; Hasegawa A; Masuda T; Takaue Y; Okamura J; Kannagi M
Cancer Res; 2004 Jan; 64(1):391-9. PubMed ID: 14729650
[TBL] [Abstract][Full Text] [Related]
12. A Unique T-Cell Receptor Amino Acid Sequence Selected by Human T-Cell Lymphotropic Virus Type 1 Tax
Ishihara Y; Tanaka Y; Kobayashi S; Kawamura K; Nakasone H; Gomyo A; Hayakawa J; Tamaki M; Akahoshi Y; Harada N; Kusuda M; Kameda K; Ugai T; Wada H; Sakamoto K; Sato M; Terasako-Saito K; Kikuchi M; Kimura SI; Tanihara A; Kako S; Uchimaru K; Kanda Y
J Virol; 2017 Oct; 91(19):. PubMed ID: 28724766
[TBL] [Abstract][Full Text] [Related]
13. [Development of Tax-redirected T-cell immunotherapy using TCR gene transduction in patients with ATL].
Tanaka Y; Kanda Y
Rinsho Ketsueki; 2015 Jul; 56(7):815-24. PubMed ID: 26251144
[TBL] [Abstract][Full Text] [Related]
14. Graft-versus-adult T-cell leukemia/lymphoma effect following allogeneic hematopoietic stem cell transplantation.
Yonekura K; Utsunomiya A; Takatsuka Y; Takeuchi S; Tashiro Y; Kanzaki T; Kanekura T
Bone Marrow Transplant; 2008 Jun; 41(12):1029-35. PubMed ID: 18332910
[TBL] [Abstract][Full Text] [Related]
15. Outcomes of Allogeneic Hematopoietic Stem Cell Transplantation for ATL with HTLV-1 Antibody-Positive Donors.
Yoshimitsu M; Fuji S; Utsunomiya A; Nakano N; Ito A; Ito Y; Miyamoto T; Suehiro Y; Kawakita T; Moriuchi Y; Nakamae H; Kanda Y; Ichinohe T; Fukuda T; Atsuta Y; Kato K;
Biol Blood Marrow Transplant; 2020 Apr; 26(4):718-722. PubMed ID: 31821886
[TBL] [Abstract][Full Text] [Related]
16. Long-term persistence of limited HTLV-I Tax-specific cytotoxic T cell clones in a patient with adult T cell leukemia/lymphoma after allogeneic stem cell transplantation.
Tanaka Y; Nakasone H; Yamazaki R; Wada H; Ishihara Y; Kawamura K; Sakamoto K; Ashizawa M; Machishima T; Sato M; Terasako K; Kimura S; Kikuchi M; Okuda S; Kako S; Kanda J; Tanihara A; Nishida J; Kanda Y
J Clin Immunol; 2012 Dec; 32(6):1340-52. PubMed ID: 22763862
[TBL] [Abstract][Full Text] [Related]
17. Prognosis of HTLV-I-positive renal transplant recipients.
Nakamura N; Tamaru S; Ohshima K; Tanaka M; Arakaki Y; Miyauchi T
Transplant Proc; 2005 May; 37(4):1779-82. PubMed ID: 15919464
[TBL] [Abstract][Full Text] [Related]
18. Universal cytotoxic activity of a HTLV-1 Tax-specific T cell clone from an HLA-A*24:02⁺ patient with adult T-cell leukemia against a variety of HTLV-I-infected T-cells.
Tanaka Y; Yamazaki R; Terasako-Saito K; Nakasone H; Akahoshi Y; Nakano H; Ugai T; Wada H; Yamasaki R; Ishihara Y; Kawamura K; Sakamoto K; Ashizawa M; Sato M; Kimura S; Kikuchi M; Kako S; Kanda J; Tanihara A; Nishida J; Kanda Y
Immunol Lett; 2014; 158(1-2):120-5. PubMed ID: 24389072
[TBL] [Abstract][Full Text] [Related]
19. Outcomes in human T-cell leukemia virus type I carriers after hematopoietic stem cell transplantation for diseases other than adult T cell leukemia/lymphoma: a Japanese national survey.
Nakano N; Nakasone H; Fuji S; Shinohara A; Suzuki R; Utsunomiya A; Eto T; Morishima S; Ikegame K; Kakinoki Y; Matsuoka KI; Mori Y; Suehiro Y; Uchida N; Ito A; Doki N; Ozawa Y; Kanda J; Kanda Y; Fukuda T; Atsuta Y; Ogata M
Lancet Reg Health West Pac; 2023 Nov; 40():100902. PubMed ID: 38106528
[TBL] [Abstract][Full Text] [Related]
20. Maintenance of long remission in adult T-cell leukemia by Tax-targeted vaccine: A hope for disease-preventive therapy.
Kannagi M; Hasegawa A; Nagano Y; Iino T; Okamura J; Suehiro Y
Cancer Sci; 2019 Mar; 110(3):849-857. PubMed ID: 30666755
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
